Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay

Similar Items

• Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA
  od: Delfau-Larue, Marie-Hélène, i dr.
  Izdano: (2012)
• Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma
  od: Jordheim, Lars P., i dr.
  Izdano: (2015)
• Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
  od: Morel, P., i dr.
  Izdano: (1994)
• Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
  od: Dubois, Sydney, i dr.
  Izdano: (2019)
• The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
  od: Mareschal, Sylvain, i dr.
  Izdano: (2011)